Skin Quality
5 min readThe Injectable 'Placenta Facial' Explained
Educational reading for licensed practitioners — not clinical or injection guidance.
Alongside the topical placenta serums and masks driving the ingredient's cosmetic revival, there is a parallel, more clinical conversation about injectable placenta preparations — often marketed to patients as a "placenta facial." The name is casual; the procedure is not. These are medical products used by trained practitioners, with a regulatory footprint that varies dramatically by country, and they deserve a clear-eyed explanation rather than the glow-treatment framing they sometimes receive online.
What the "Placenta Facial" Refers To
In practice the term covers the use of purified human placenta extract (HPE) delivered into the skin as a skin-quality treatment, rather than as a volumiser. Preparations such as the Laennec and Curacen lines are the products usually meant. The proposed goal is conditioning of the tissue — supporting hydration, tone and the general "quality" of the skin — drawing on the amino acids, peptides, cytokines and growth factors that placenta extract contains.
This places the treatment conceptually alongside other skin-quality injectables such as polynucleotides or mesotherapy cocktails, even though its composition is distinct. It is not a filler, and it is not marketed as one.
How It Is Delivered
Two broad approaches appear in professional settings. The first is a series of superficial microinjections across a treatment area — the technique that most closely earns the "facial" label. The second is delivery through microneedling or a nappage-style application, where a placenta essence formulated for the purpose, such as the Curacen essence, is worked into channels created in the skin. Protocols typically involve a course of sessions rather than a single visit, with the aim of a cumulative conditioning effect.
Because these are professional procedures, the same standards apply as to any injectable: sterile technique, appropriate patient selection, informed consent and realistic expectations. The word "facial" should not lull anyone — practitioner or patient — into treating it as a spa add-on.
Where the Evidence Stands
The research base for placenta extract is real but narrower than for mainstream HA injectables, and much of it originates from South Korean and Japanese groups. Studies have explored antioxidant and anti-inflammatory effects and tissue-repair properties, and in some East Asian markets HPE-based products hold specific medical approvals for defined indications — which is a separate pathway from cosmetic skin-quality use and should not be conflated with it.
For the aesthetic "placenta facial" specifically, the honest position is that this is an area of continued interest supported by a plausible growth-factor mechanism, not a settled consensus backed by large controlled trials. Claims should be framed as "reported" and "proposed," and no outcome should be guaranteed.
The Regulatory Reality
This is the point that most distinguishes injectable placenta from its topical cousins. Injectable HPE is subject to the widest variation in regulatory status of any format: a product that is a licensed, prescription-only medical treatment in one country may be entirely unavailable, or permitted only as a cosmetic-grade topical, in another. Practitioners must confirm what is legally available and permitted in their own jurisdiction before offering any placenta-derived injectable, and must not assume that availability abroad implies approval at home.
Patients researching the treatment should understand that its legal standing is genuinely country-specific, and that a treatment offered legitimately in one market may sit outside the approved framework elsewhere.
Sourcing and Safety
As a donor-derived biological material, injectable HPE raises sourcing questions that synthetic products do not. Reputable manufacturers document rigorous viral and pathogen screening, defined sterilisation standards and batch-level traceability. These are baseline requirements, not premium extras. A supplier unable to provide donor-screening protocols, batch testing records and a clear sterilisation method on request is not a suitable source for an injectable of this kind, however established the brand name appears.
Practitioners should also weigh candidate suitability carefully, take a full history, and treat allergy and reaction potential with the seriousness any biological injectable warrants.
The Takeaway
The injectable "placenta facial" is a skin-quality procedure using purified placenta preparations, delivered by microinjection or through microneedling, with a plausible mechanism and a modest but genuine evidence base. Its defining challenge is regulatory: legal status varies enormously by country, and documented sourcing is non-negotiable. Approached with the rigour of any injectable — not the informality its nickname suggests — it is a considered option for skin quality. Clinics can review the available preparations across the placenta range.